BP vs CNX

BP's Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to its Graham Number ($7.35) and even the growth-based intrinsic value ($18.88), currently priced at $36.53, driven by high forward earnings expectations. While profitability metrics and dividend yield are attractive, elevated valuation multiples, inconsistent earnings surprises, and a dangerously high payout ratio of 315% raise sustainability concerns. Analysts recommend a 'buy' with a target of $38.73, supported by strong insider sentiment, though no insider transactions have occurred recently.

CNX presents a dichotomy of exceptional profitability and concerning short-term liquidity. With a Piotroski F-Score of 4/9, the company is categorized as stable but lacks the financial strength of a high-score firm. While the Graham Number ($52.19) suggests significant defensive undervaluation and revenue growth is robust at 41.2%, these positives are countered by a dangerously low current ratio (0.44) and bearish insider sentiment.